Skip to main content
NVDA-0.70%AAPL+0.73%GOOGL-2.28%MSFT-0.17%AMZN+0.02%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.66%TSLA-1.32%SKHY+7.05%MU-1.81%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.22%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.34%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.59%AUDJPY-1.51%USDJPY-1.35%EURJPY-1.30%GBPJPY-1.24%CADJPY-1.21%NZDCAD-0.99%GBPNZD+0.94%EURNZD+0.92%NZDUSD-0.86%AUDNZD+0.70%USDNOK+0.65%NZDCHF-0.63%USDZAR+0.53%EURNOK+0.53%CHFNOK+0.46%USDSEK+0.42%EURZAR+0.41%GBPTRY+0.41%GBPZAR+0.40%CADCHF+0.36%AUDCAD-0.33%GBPCHF+0.33%GBPHKD+0.32%EURSEK+0.29%AUDNOK+0.29%GBPMXN-0.28%EURCHF+0.28%USDTHB+0.28%NOKJPY-0.27%USDPLN+0.25%GBPAUD+0.25%USDCHF+0.25%AUDDKK-0.24%SGDJPY+0.24%CHFSEK+0.22%USDMXN+0.22%AUDSGD-0.22%EURAUD+0.21%AUDUSD-0.16%USDILS+0.16%USDSGD+0.15%EURHKD-0.14%PLNJPY+0.13%USDCAD-0.13%USDDKK+0.13%EURPLN+0.12%USDTRY+0.11%GBPUSD+0.10%EURCAD-0.10%EURCNH-0.08%AUDCHF+0.08%EURCZK-0.08%NZDMXN+0.07%GBPCAD-0.05%CHFSGD-0.04%EURUSD+0.04%EURGBP-0.04%USDCOP-0.04%EURSGD+0.03%USDCNH+0.02%NZDSGD+0.02%GBPSGD+0.02%USDHKD+0.01%EURDKK0.00%HG1-4.16%XPTUSD-3.63%XAGUSD-2.51%GAGUSD-2.51%COFFEE-2.48%SUGAR+1.85%USOIL+1.66%UKOIL+1.57%COTTON+0.98%S1+0.73%COCOA-0.72%C1+0.71%BTCUSD-0.58%ETHUSD-0.24%USDTUSD-0.06%XRPUSD-1.26%SOLUSD-0.43%TRXUSDT+0.50%ZECUSDT-1.89%DOGEUSD-1.09%XMRUSDT-1.13%LINKUSD+0.26%XLMUSD-0.97%BCHUSDT-2.60%LTCUSD-1.77%UNIUSD-2.02%TONUSD+24.88%HBARUSDT-1.05%SUIUSD-1.33%TAOUSDT-1.05%AAVEUSD-2.18%DOTUSDT-2.01%ICPUSDT-1.15%ONDOUSDT-1.98%WLDUSDT-1.47%ATOMUSDT-2.97%ARBUSDT-0.97%JUPUSDT-2.53%INJUSDT-2.13%STXUSDT-2.34%FETUSDT-2.59%TIAUSDT-0.08%PYTHUSDT-0.42%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.83%OPUSDT-0.99%POLUSDT-5.19%IOTAUSDT-2.94%AXSUSDT-1.82%FARTCOINUSDT-2.72%EOSUSDT-0.06%DYDXUSDT+1.06%ORDIUSDT-0.16%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.70%AAPL+0.73%GOOGL-2.28%MSFT-0.17%AMZN+0.02%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.66%TSLA-1.32%SKHY+7.05%MU-1.81%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.22%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.34%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.59%AUDJPY-1.51%USDJPY-1.35%EURJPY-1.30%GBPJPY-1.24%CADJPY-1.21%NZDCAD-0.99%GBPNZD+0.94%EURNZD+0.92%NZDUSD-0.86%AUDNZD+0.70%USDNOK+0.65%NZDCHF-0.63%USDZAR+0.53%EURNOK+0.53%CHFNOK+0.46%USDSEK+0.42%EURZAR+0.41%GBPTRY+0.41%GBPZAR+0.40%CADCHF+0.36%AUDCAD-0.33%GBPCHF+0.33%GBPHKD+0.32%EURSEK+0.29%AUDNOK+0.29%GBPMXN-0.28%EURCHF+0.28%USDTHB+0.28%NOKJPY-0.27%USDPLN+0.25%GBPAUD+0.25%USDCHF+0.25%AUDDKK-0.24%SGDJPY+0.24%CHFSEK+0.22%USDMXN+0.22%AUDSGD-0.22%EURAUD+0.21%AUDUSD-0.16%USDILS+0.16%USDSGD+0.15%EURHKD-0.14%PLNJPY+0.13%USDCAD-0.13%USDDKK+0.13%EURPLN+0.12%USDTRY+0.11%GBPUSD+0.10%EURCAD-0.10%EURCNH-0.08%AUDCHF+0.08%EURCZK-0.08%NZDMXN+0.07%GBPCAD-0.05%CHFSGD-0.04%EURUSD+0.04%EURGBP-0.04%USDCOP-0.04%EURSGD+0.03%USDCNH+0.02%NZDSGD+0.02%GBPSGD+0.02%USDHKD+0.01%EURDKK0.00%HG1-4.16%XPTUSD-3.63%XAGUSD-2.51%GAGUSD-2.51%COFFEE-2.48%SUGAR+1.85%USOIL+1.66%UKOIL+1.57%COTTON+0.98%S1+0.73%COCOA-0.72%C1+0.71%BTCUSD-0.58%ETHUSD-0.24%USDTUSD-0.06%XRPUSD-1.26%SOLUSD-0.43%TRXUSDT+0.50%ZECUSDT-1.89%DOGEUSD-1.09%XMRUSDT-1.13%LINKUSD+0.26%XLMUSD-0.97%BCHUSDT-2.60%LTCUSD-1.77%UNIUSD-2.02%TONUSD+24.88%HBARUSDT-1.05%SUIUSD-1.33%TAOUSDT-1.05%AAVEUSD-2.18%DOTUSDT-2.01%ICPUSDT-1.15%ONDOUSDT-1.98%WLDUSDT-1.47%ATOMUSDT-2.97%ARBUSDT-0.97%JUPUSDT-2.53%INJUSDT-2.13%STXUSDT-2.34%FETUSDT-2.59%TIAUSDT-0.08%PYTHUSDT-0.42%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.83%OPUSDT-0.99%POLUSDT-5.19%IOTAUSDT-2.94%AXSUSDT-1.82%FARTCOINUSDT-2.72%EOSUSDT-0.06%DYDXUSDT+1.06%ORDIUSDT-0.16%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%
NB

Nuvation Bio Inc. (NUVB)

NYSE • Healthcare

$6.52
-$0.09 (-1.4%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$6.56
Day Range$6.5 - $6.72
Avg. Volume (3M)5M
Market Cap$2.2B
52 Week Range
$2.99$9.75
Next EarningsIn 53 daysNov 2, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$31.6M100%
Gross Profitminus cost of goods$30.7M97%

Fundamentals & Financials

Revenue (TTM)
$169.9M
Net Income (TTM)
-$149.8M
EPS (TTM)
-$0.43
ROA (TTM)
-20.12%
Current Ratio
8.37

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

0.0%Q1 2026-$0.11
+135.7%Q2 2026$0.01
-5.9%Q3 2026-$0.15
Next

Nov 2

in 53 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -5.9%

Nuvation Bio's second fiscal quarter of 2026, reported Aug. 6, topped revenue consensus even as adjusted EPS missed. Revenue rose about 556% to roughly $31.7 million from about $4.8 million a year ago, beating the roughly $27.0 million consensus by about 17%. Adjusted EPS of -$0.15 missed the roughly -$0.14 estimate by about 6%, but improved about 12% from -$0.17 a year ago. Gross margin held near 97%, while operating margin was around -161% and operating income stayed negative at about $51.0 million. Net income was about negative $62.8 million, down about 7% from about negative $59.0 million a year ago. The company also reported negative operating cash flow of about $5.1 million and repurchased about $17.1 million of stock. Consensus for the next period calls for adjusted EPS of -$0.13 on revenue of $38.6 million.

View full earnings history

About Nuvation Bio Inc.

Nuvation Bio Inc. is a NYSE-listed biotechnology company that discovers and develops cancer therapies. In FY2025, it recorded $62.9 million in revenue. The company operates as a clinical-stage biopharmaceutical business focused on advancing treatments for oncological conditions through a pipeline of targeted small molecules and a drug-drug conjugate platform.

Name
Nuvation Bio Inc.
CEO
David T. Hung
Website
www.nuvationbio.com
Industry
Healthcare
Year Founded
2018
Employees
305

Today's Snapshot

AI-generated

The day ended with NUVB 1.4% lower at 6.52, while its sector was flat. Trading was lighter than usual, with volume about two-thirds of its usual level. Nuvation Bio outlined its growth plans at a Citigroup biopharma summit.

Trading Volume

Below 10d avg (3.8M)

2.2M

vs S&P 500 Today

Underperforming Market

-0.94%

Updated: September 9, 2026 at 20:10 UTC

Technical Indicators

4 Buy2 Neutral2 Sell
NUVB presents a buy bias driven by longer-term moving averages trading below the current market even as short-term indicators are mixed. The price around 6.52 sits below the nearest short-term averages but remains above the 50/100/200 period averages, stochastic and Williams%R show short-term buying interest, while RSI and MACD are neutral and ADX near 13 points to a weak trend. ATR as a percentage is elevated, and OBV flags weaker volume, with the pivot overhead. Technical takeaway: longer-term moving averages support a buy stance despite weak trend and light volume.
All signals
  • EMA (5 indicators)$5.79 - $6.71
    Buy
  • RSI (14)47.81
    Neutral
  • Stochastic %K (14, 3, 3)15.71
    Buy
  • MACD Level (12, 26)0.09
    Neutral

Peers & Related Assets

EWTXEdgewise Therapeutics, Inc.
$43.39-1.0%
CLDXCelldex Therapeutics, Inc.
$38.78-0.9%
VRDNViridian Therapeutics, Inc.
$22.73-1.9%
OCULOcular Therapeutix, Inc.
$11.47+0.9%
VERAVera Therapeutics, Inc.
$33.78-4.3%
AUPHAurinia Pharmaceuticals Inc.
$16.25+1.1%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.